Announcements
- Relief Therapeutics Announces Executive Changes
- Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders
- Relief Therapeutics Announces New Executive Leadership Team strengthening capabilities to guide the Company through pipeline development initiatives
- Relief Therapeutics has published its Annual Report
- RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
- RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting
- Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.80 |
---|---|
High | 0.80 |
Low | 0.80 |
Bid | 0.002 |
Offer | 0.0064 |
Previous close | 0.80 |
Average volume | -- |
---|---|
Shares outstanding | 14.04m |
Free float | 10.75m |
P/E (TTM) | -- |
Market cap | 17.55m CHF |
EPS (TTM) | -8.45 CHF |
Data delayed at least 15 minutes, as of Jun 28 2019.
More ▼